Effects of aspirin on nasal responses in atopic subjects.
Preliminary experiments indicated that solutions of aspirin (ASA) in buffered saline, pH 7.35, did not significantly change nasal airways resistance (NAR) when 0.1 ml of solution containing 22.5 mg (or less) per deciliter was sprayed into each nostril. Subsequently it was shown that this quantity of ASA administered intranasally did not significantly change NAR responses 15 min later to intranasal administration of increasing concentrations of histamine, methacholine, or an irritant (NH3 gas). However, the same atopic subjects demonstrated significantly decreased responses to intranasal challenge with short ragweed extract (SRW) after intranasal ASA. In addition, prior oral administration of ASA, Na salicylate, and indomethacin significantly inhibited nasal challenge responses to SRW in sensitive subjects under controlled conditions.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000403:Airway Resistance / Q000187:drug effects*; D000485:Allergens / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage*; D001667:Binding, Competitive; D006632:Histamine / Q000008:administration & dosage; D006801:Humans; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000008:administration & dosage; D009299:Nasal Provocation Tests; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D012996:Solutions
D000485:Allergens; D008688:Methacholine Compounds; D012996:Solutions; D016210:Methacholine Chloride; D006632:Histamine; D001241:Aspirin